Winston-Salem, North Carolina. Javara Inc., today announced the launch of its Integrated Research Organization (IRO) platform to drive innovative research partnerships, service, and technology offerings to healthcare systems, including
Accountable Care Organizations, Academic and Community-Based systems. Together, Javara and its healthcare partners will offer a more aligned, efficient, and effective solution to the challenges of patient inclusion in clinical trials, by creating an infrastructure where clinical research will become an integral part of the state-of-the-art healthcare delivery offered by Javara’s healthcare partners.
“Today, biopharmaceutical companies are developing truly innovative therapies for patients. Yet, patients, who simply cannot wait, continue to face incredible challenges in accessing clinical trials and frustration in the slow completion of clinical trials,” said Jeff Kasher, Ph.D, Pharmaceutical Development Executive and Javara Board Director. “By focusing on the healthcare ecosystem, Javara aims to make clinical research more efficient, relevant, and more accessible.”
Jennifer Byrne, co-founder and CEO of Javara is a long time clinical research leader with a proven track record. Under her leadership, Javara has assembled a top-flight talent team and a blue-chip Board of Directors (www.javararesearch.com), all deeply committed to advancing the relevance and efficiency of clinical research to the healthcare ecosystem. The Javara IRO platform will bring better outcomes for patient-centered care, better economic results and easier access to cutting edge therapies for healthcare systems, and a more valuable and reliable research delivery model to the biopharmaceutical sector. Ms. Byrne commented, “Strong market forces are driving the need for transformational and innovative partnerships for both healthcare organizations and drug and device developers, all while delivering a higher quality and higher touch clinical trial experience to patients. Historically, healthcare and drug development sectors have largely operated in silos. Javara’s mission is to build extraordinary bridges between healthcare and the research industry to effectively and efficiently accelerate drug development.”
Jennifer Byrne
CEO Javara
jbyrne@javararesearch.com
(336) 414-0814
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.